F ailure of the coronary circulation to meet the constant demands of the cardiomyocytes results in ischemic heart disease or infarction. Determining the factors that regulate coronary blood flow is, therefore, crucial for understanding pathophysiological manifestations and for the development of new therapeutic strategies. Voltage-gated potassium channels (K V ) have been implicated in the control of the coronary circulation and reactive hyperemia, 1,2 but little is known about the specific molecular components. Kv channels encoded by KCNQ1-5 (K V 7.1-K V 7.5) are important regulators of the smooth muscle resting membrane potential and contractility in several different rodent and human arteries, [3] [4] [5] [6] [7] [8] [9] [10] [11] which are known to be compromised in animal models of primary and secondary hypertension. 3, 6 These channels, in particular K V 7.4, are also functional end points in β-adrenoceptor-mediated relaxations.
Functional Studies
Isometric tension studies were performed on isolated first-, second-, and third-order LAD coronary artery branches (2-4 vessels per animal). Measurements of vessel diameter and basal tone after normalization are illustrated in Figure S1 in the online-only Data Supplement. Coronary flow was measured in isolated perfused heart preparations. Cardiac ischemia was induced by stopping perfusion for 90 s.
Expression Studies
Expression profiles of KCNQ1-5 and the auxiliary subunits KCNE1-5 were measured using quantitative polymerase chain reaction (PCR) in LAD coronary arteries from both normotensive rats and SHRs. Primer sequences are listed in Table S1 .
Protein expression of K V 7.4 in coronary arteries from the first-, second-, and third-order LAD branches of normotensive and hypertensive rats was determined by Western blotting.
Statistical Analysis
A 2-way ANOVA test followed by a Bonferroni post hoc test was used for comparing the effects of K V 7 activators and blockers in normotensive and hypertensive animals. Effects of adenosine, A2 (CGS-21680), cAMP analogue (8-Br-cAMP), and protein kinase A inhibitors in normotensive rats were compared with the dimethyl sulfoxide (DMSO) control using a 2-way ANOVA test followed by a Bonferroni post hoc test. A 1-way ANOVA test followed by Tukey's multiple comparison post-test was used to compare the effect of DMSO and K V 7 blockers on resting coronary flow. An unpaired t test was used to compare the effect of (S)-1 and (S)-1+K V 7 channel inhibitor on isolated hearts and to analyze the effect of K V 7 blockers on reactive hyperemia indices. In all tests, P values <0.05 were considered to be significant.
Drugs
(S)-1, BMS-254352, and retigabine were synthesized at NeuroSearch A/S (Ballerup, Denmark). U46619, linopirdine, XE-991, isoproterenol, adenosine, CGS-21680, 8-Br-cAMP, KT5720, H89, and SNP were purchased from Sigma-Aldrich (Brøndby, Denmark). R-L3 was purchased from Tocris (Abingdon, United Kingdom) and HMR1556 was from Janssen Pharmaceuticals (Belgium).
Results

Effect of K V 7 Channel Blockers and Activators in Coronary Arteries
Cumulative application of the pan-K V 7 channel inhibitors XE-991 or linopirdine (1, 3, 5, or 10 μmol/L) to LAD coronary arteries isolated from normotensive rats produced a concentration-dependent contraction that was not observed in coronary arteries from SHRs ( Figure 1 ) and not seen with the K V 7.1-specific blocker HMR1556 ( Figure S2 ). To calibrate the system, we used cumulative addition of U46619 within a concentration range of 0.1 to 10 nmol/L in normotensive rat and SHR vasculature to match the same contraction achieved by applying 60 mmol/L KCl ( Figure S3 ). Coronary arteries preconstricted by 1 nmol/L U46619 were relaxed by structurally different K V 7.2 to 7.5 channel activators (S)-1, BMS-254352, and retigabine with an order of potency (S)-1=BMS-204352>retigabine ( Figure 2B ). All relaxations to these agents were abrogated by preincubation with 10 μmol/L linopirdine ( Figure 2D ) but were not affected by removal of the endothelium that ablated the response to 10 µmol/L carbachol ( Figure S4 ). The response to (S)-1 was the same in all branches of the LAD coronary arteries ( Figure S4C ). The K V 7.1 activator R-L3, recently shown to relax mesenteric and pulmonary arteries, 4 had no effect on precontracted coronary arteries in a concentration range of 1 to 10 μmol/L ( Figure 2D ). The vasorelaxant effects of the K V 7.2 to 7.5 activators were absent in coronary arteries isolated from SHRs ( Figure 2C and 2D) although they relaxed fully on application of the Ca 2+ -channel blocker nicardipine (10 nmol/L) or the ATPsensitive K + channel activator pinacidil (10 µmol/L; Figure S5 ). These data indicate that K V 7 channels are active regulators of coronary arteries from normotensive but not hypertensive rats.
K V 7 and KCNE Expression in Rat Coronary Arteries
Quantitative PCR experiments showed that coronary arteries expressed KCNQ1, 4, and 5 with negligible contribution from KCNQ2 or 3 ( Figure 3A ). Similar to previous work, [4] [5] [6] 14 we found that LAD coronary arteries from SHRs exhibited considerably less K V 7.4 protein compared with arteries from Concentration-dependent effect curve of K V 7 inhibitor XE-991 and linopirdine (C) in NT and spontaneously HT rats on arterial tone. Data are mean±SEM. A 2-way ANOVA followed by a Bonferroni post-test was used. § § §P<0.001 for differences between the effect of K V 7 inhibitor XE-991 or linopirdine in NT rats compared with vehicle; ***P<0.001 for differences between the effect of K V 7 inhibitor XE-991 or linopirdine in NT compared with HT rats.
by guest on June 20, 2017 http://hyper.ahajournals.org/ Downloaded from normotensive rats ( Figure 3B ). However, this was not because of a change in transcript level ( Figure 3C ) although KCNQ1 and KCNQ4 transcripts were decreased ≈6-fold in rat aorta in line with previous work (Figure 3D-i) . 6 Mesenteric arteries also showed no change in KCNQ transcription ( Figure 3D -ii). Coronary arteries also expressed all members of the KCNE gene family except KCNE1 ( Figure 3E-i) , and the expression of these genes was unchanged in arteries from SHRs ( Figure 3E -ii).
Role of K V 7 Channels in Vasodilatory Response to Adenosine
Experiments were performed to ascertain the contribution of K V 7 channels to the physiological responses to adenosine. Both adenosine and the A2 receptor-selective agonist CGS-21680 relaxed precontracted coronary arteries by ≈25% to 30%, which was abrogated by prior incubation with 10 µmol/L linopirdine ( Figure 4 ). Adenosine-mediated relaxations were also considerably less in coronary arteries from SHRs ( Figure 4B ). Consistent with this intracellular signaling pathway, the cell permeable cAMP analogue 8-Br-cAMP also produced concentration-dependent relaxations that were sensitive to linopirdine pretreatment ( Figure S6A ). To investigate whether protein kinase A activity is involved in regulating K V 7 activity by adenosine, we incubated normotensive coronary arteries with the protein kinase A inhibitors KT5720 or H89 for 1 hour. Inhibition of protein kinase A fully antagonized the dilative response to adenosine ( Figure S6B ). Application of isoproterenol resulted in linopirdine-sensitive vasorelaxations that were less pronounced in SHR arteries ( Figure S7 ), whereas the NO donor sodium nitroprusside produced relaxations that were not affected by K V 7 blockade ( Figure S8 ).
Isolated Perfused Heart Preparations
Ex vivo experiments were performed to determine the impact of K V 7 blockade on coronary blood flow under normal and stressed conditions ( Figure 5 ). We applied XE-991 (3 µmol/L) or linopirdine (10 µmol/L) in isolated, perfused heart preparations. Prolonged infusion with XE-991 or linopirdine to the isolated hearts from normotensive rats produced a decrease in coronary blood flow compared with DMSO-perfused hearts ( Figure 5A ). Coronary K V 7 channels were efficiently blocked by the used concentrations as evidenced by a significantly diminished effect of (S)-1 (10 µmol/L) on coronary flow, when coinfused with either XE-991 or linopirdine ( Figure 5B ). Having established that K V 7 channels contribute to coronary flow under resting conditions, we tested whether pharmacological blockade of K V 7 channels had any effect on mechanisms regulating coronary flow, such as autoregulation, tachycardia-induced vasodilation, and reactive hyperemia. Infusion of a K V 7 channel blocker to the heart had effect neither on coronary autoregulatory function nor on tachycardia-induced vasodilation ( Figure 5C and 5D). In contrast, coronary reactive hyperemic responses after Figure 6A) . A clearly attenuated level of reactive hyperemia was also observed in hearts from SHRs. As excess hyperemic flow depends on the preocclusion flow rate, the flow debt (preocclusion flow multiplied by ischemia duration) is lower in the hearts infused with a K V 7 blocker (Table S2) . Nevertheless, the percentage of flow repayment, which reflects the total flow at reperfusion normalized to flow debt, was still decreased in hearts with blocked K V 7 channels. In addition, the hyperemic peak flow and total duration of reactive hyperemia were reduced on XE-991 or linopirdine infusion (Table S2) . Overall, the data indicate that coronary K V 7 channels contribute to the restoration of cardiac reperfusion after transient coronary occlusion.
Discussion
K V 7 channels are important regulators of vascular tone in several arteries, including mesenteric, renal, and cerebral arteries 6, 11 where K V 7 blockers promote vasospasm, and K V 7 activators are effective vasorelaxants. 4, 6, 7, 11, 14, 15 Moreover, evidence is accumulating that activation of K V 7 channels contributes to the vasodilatory response of various endogenous molecules, including β-adrenoceptor agonists 3 and H 2 S. 16 In addition, mesenteric and renal arteries from hypertensive animals exhibit considerable attenuated response to K V 7 activators and marked reduction in K V 7.4 abundance. 6, 14 The present study now reveals that coronary arteries express KCNQ1, 4, and 5 transcripts, as well as all members of the KCNE gene family except KCNE1. In addition, it shows that structurally different K V 7.2 to 7.5 activators ((S)-1, BMS-254352, and retigabine) are effective relaxants of precontracted coronary arteries at all orders of artery, whereas the K V 7.1 activator R-L3 has no relaxant effect at concentrations where it relaxes mesenteric and pulmonary arteries. 4 Importantly, the relaxant effect of the K V 7.2 to 7.5 activators was markedly impaired in coronary arteries from SHRs similar to findings in aorta, mesenteric and renal arteries, 6, 14 which was associated with a reduction in K V 7.4 protein abundance. In contrast to the rat aorta, 6 there was no change in KCNQ expression in the coronary arteries or mesenteric arteries (also observed in gracilis muscle arteries from SHRs). 10 This suggests that the decrease in K V 7.4 reflects an alteration in protein handling rather than transcriptional control. It is worth stressing that we detected an even greater reduction in KCNQ1 and KCNQ4 transcripts in the aorta compared with our previous study because we used a more rigorous quantification technique based around the geNorm analysis of stable housekeeping genes.
The present work also showed that K V 7 blockers attenuated basal coronary blood flow and reduced all indices of reactive hyperemia in normotensive rats after brief cessation of perfusion as well as abrogating the response to adenosine and the A2A receptor-specific agonist CGS-21680. Adenosine is a key mediator of coronary ischemic vasodilation, which contributes to amelioration of reperfusion injuries. [17] [18] [19] [20] Levels of this molecule increase ≈3-fold within 5 s of myocardial ischemia in vivo, 17 and the increase in coronary flow correlates highly with the rapid release of endogenous adenosine [21] [22] [23] [24] and the activation of the adenosine 2A receptor. 13, [25] [26] [27] [28] Pharmacological blockade of adenosine receptors or limiting myocardial adenosine concentration during hypoxia and reperfusion results in diminished repayment flow and peak hyperemic flow in various animal species both in vivo and in isolated, perfused hearts. 18, [29] [30] [31] Activation of adenosine receptors leads to increased intracellular cAMP and possible stimulation of protein kinase A, but little is known about the downstream signals although recruitment of ATP-sensitive K channels has been implicated in porcine but not human coronary arteries. 25 We recently proposed that the β-adrenoceptor agonist isoproterenol relaxed renal arteries through a cAMP-dependent recruitment of K V 7 channels and K V 7.4, in particular.
14 Our pharmacological modulation of adenosine and isoproterenol-mediated responses with K V 7 blockers and the poor response in arteries from SHRs suggests that a similar paradigm exists in the coronary circulation. As such, K V 7 channels provide a crucial functional end point for adenosine-mediated signaling. In agreement with a key role for K V 7 channels in coronary perfusion and reactive hyperemia, we show that K V 7 blockade has a similar effect on all parameters of the coronary reperfusion (ie, duration, magnitude, flow repayment, and debt) as produced by adenosine antagonists. Our data provide an important insight into the molecular mechanisms that underlie key physiological mechanisms in coronary circulation and implicate K V 7 channels as therapeutic targets in coronary ischemia. Moreover, the identification that K V 7.4 becomes dysfunctional in hypertension provides a mechanism for coronary artery underperfusion and compromised reactive hyperemia in hypertensive individuals although changes in adenosine receptor number and other factors may also occur. Future studies will strive to determine the factors that dictate K V 7.4 abundance.
Perspectives
In the present study, we show that K V 7 channels are expressed in rat coronary arteries. We provide evidence that they are important for regulating coronary artery contractility and coronary flow. Furthermore, using pharmacological tools we demonstrate that K V 7 channels have a central role in adenosine regulation of coronary artery contractility. Interestingly, in tissue from spontaneously hypertensive rats, the vasodilatory effect of adenosine was abolished. In line with this, we found a reduced K V 7 protein expression in hypertensive animals.
Adenosine levels increase on myocardial ischemia. Consequently, the release of adenosine is important for the hyperemic response that is the transient increase in blood flow after brief periods of ischemia. We found that K V 7 channels are involved in the reactive hyperemic response as inhibition of the channels attenuated the response. Overall, our findings provide evidence for a functional role of K V 7 channels in the coronary circulation under physiological conditions and after ischemic insults. Noteworthy, the vasodilatory potential of K V 7 in the coronary arteries was diminished in the hypertensive rat. Therapeutic strategies for improving K V 7 function could be of potential interest in clinical settings of reduced coronary flow.
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Contribution of K V 7 channels to basal coronary flow and active response to ischemia 
SUPPLEMENTAL METHODS
Isometric Tension Recordings
First, second and third order branches of LAD coronary arteries from normotensive and hypertensive rats were carefully dissected and transferred to ice-cold Krebs Solution (in mmol/L: 133 NaCl, 4.6 KCl, 2.5 CaCl 2 ,16.3 NaHCO 3 , 1.75 Na 2 HPO 4 , 0.6 MgSO 4 , 10 glucose) and cleaned from adherent connective tissue. These vessels were threaded on 40 µm tungsten wires and mounted in an isometric wire myograph chamber (DanishMyo Technology, Aarhus, Denmark) containing Krebs solution constantly aerated with 95% O 2 /5% CO 2 at 37°C. All vessels were subjected to a standard warm-up protocol where they were repeatedly stimulated with 60 mmol/L KCl. PowerLab4/25-Chart5 and 7 acquisition systems (ADInstruments Ltd, Oxford, UK) were used to record force which was converted to tension by dividing the force with double the segment length. By cumulative addition of the synthetic analog of prostaglandin U46619 within a concentration range of 0.1-10 nmol/L a stabile vessel contraction corresponding to the same contraction achieved by applying 60-100 nmol/L KCL was determined to be 1nmol/L U46619. 
Langendorff-Perfused Hearts
Rats were anesthetized and anticoagulated by intraperitoneal injection of heparin (1000 UI/kg). The hearts were excised, placed in ice-cold perfusion solution and mounted on a perfusion system (Hugo Sachs Elektronik-Harvard Apparatus GmbH, March-Hugstetten, Germany) and perfused in the Langendorff mode at constant perfusion pressure (80 mmHg) with warm (37°C) modified Krebs-Henseleit (KH) solution (in mmol/L: 118.0 NaCl, 4.7 KCl, 2 CaCl 2 , 1.2 KH 2 PO 4 , 1.2 Mg 2 SO 4 , 2.0 sodium pyruvate, 24.9 NaHCO 3 , and 10.0 glucose, pH of 7.4-7.5). KH solution was continuously aerated with 95 % O 2 /5 % CO 2 and was filtered through an in-line 0.45 μm Sterivex-HV filter (Millipore A/S, Hellerup, Denmark) before delivery to the heart. Coronary flow was monitored via an ultrasonic flow meter probe (Transonic Systems Inc., Ithaca, USA) located above the aortic cannula. Electrical activity of the heart was assessed from volume-conducted ECG, recorded via four Ag/AgCl electrodes placed in the perfusate-filled chamber around the heart preparation. Aortic pressure, coronary flow, ECG and perfusate temperature were continuously monitored using the 16-channel Powerlab system (ADInstruments, Oxford, UK) and recorded by LabChart 7 software. All pharmacological agents ((S)-1, XE-991, linopirdine) and DMSO were infused to the heart via perfusate. Subsequently, the effect of blocking K V 7 channels on tachycardia-induced vasodilation was investigated by increasing the pacing frequency from basic rate of 380 to 440, 500 and 600 bpm at 150 second intervals. Reactive hyperemic responses were induced by 30 seconds and 90 seconds of no-flow to the cannulated aorta and thereby the coronary arteries, global ischemia periods, followed by at least 8-9 minutes of reperfusion at which coronary flow returned to the pre-occlusion levels. The following indices of reactive hyperemic responses were assessed: basal flow rate (mL/min) [mean flow rate over 2 min pre-occlusion], flow debt (mL) [basal flow rate (mL/min) multiplied by ischemia duration (min)], excess hyperemic flow (mL) [integral of flow over initial 5 min of reperfusion (mL) minus integral of flow over 5 min pre-occlusion (mL)], flow repayment (%) [excess hyperemic flow (mL)x100% divided by the flow debt (mL)], duration of reactive hyperemia (s) [time span from the start of reperfusion to the return of the flow rate to the level 5% higher than basal value], peak hyperemic flow rate (mL/min) [maximal flow at reperfusion].
Quantitative Polymerase Chain Reaction
Total RNA was extracted from first order LAD coronary arteries from normotensive and hypertensive rats using the RNeasy Micro Kit (Qiagen, Manchester, UK) as described RNA was quantified using a Nanodrop Spectrophotometer (LabTech International, Carlson City, U.S) and reverse transcribed with Oligo(dT)12-18 primers and Moloney Murine Leukemia Virus (M-MLV; Invitrogen, Paisley, UK). Negative controls (RT-) were carried out in the absence of M-MLV to check for genomic contamination. Quantitative mRNA analysis was determined in duplicate reactions of 10 µL volumes using Precision-iC SYBR green master mix (PrimerDesign, Ltd., Southampton, UK) with the CFX96™ Real-Time PCR Detection System (Biorad, Hertfordshire, UK). Cycle threshold (Ct) values were determined using BioRad CFX96 software and the single threshold mode. To determine the optimal reference genes we used the rat geNorm Reference Gene Selection Kit (PrimerDesign, Ltd., UK), consisting of 12 commonly used reference genes, which were run on normotensive rat (n=3-6) and SHR (n=3-6) LAD coronary artery cDNA samples. The data were then analyzed with geNorm software to determine the best reference gene(s) and number of reference genes required for the most accurate gene normalization (Vandesompele et al., 2002) . For the coronary artery experiments the optimal number of reference genes was 2 (where geNorm V < 0.15): β-Actin and GAPDH. In the aorta the reference genes used were CYC1 and MDH1, and in the mesenteric artery ATP5B and YWHAZ were used as reference genes, determined under our experimental conditions as the most stable in the given samples (PrimerDesign, Ltd., UK). No template controls (NTCs) were run alongside all reactions to assess contamination. To determine the change in KCNQ1-5 and KCNE1-5 expression between normotensive rat and SHR arteries, the 2 -ΔΔCt method was used (Livak and Schmittgen, 2001). Primer sequences are listed in Suppl. Table S1 .
Western Blot Analysis LAD coronary arteries from normotensive (n=3-9) and hypertensive rats (n=3-9) were homogenized in 200 µL lysis buffer (2 mmol/L EDTA, 20 mmol/L Tris base, 1% NP40, 137 mmol/L NaCl, 10% glycerol, 10 µL/mL protease inhibitor cocktail; Sigma-Aldrich, Brøndby, Denmark), centrifuged to remove cell debris, and denatured at 95ºC for 5 minutes in the presence of reducing agent and sample buffer (Invitrogen, Naerum, Denmark). Proteins were separated on 4-12% SDS-polyacrylamide gels (Invitrogen) and transferred to immunoblot PVDF membranes (Amersham Biosciences, Buckinghamshire, UK). Membranes were blocked with 5% milk in PBS-Tween (0.1%) and incubated with the primary antibody against K V 7.4 (1 μg/mL; Santa Cruz, sc-50417, UK). The membrane was washed, reprobed for β-actin (0.4 μg/mL; Sigma-Aldrich, A1978, Germany) and visualized by enhanced chemiluminescence (ECL) staining. All bands were normalized against β-actin. 
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